Hypermetabolism is a reality in amyotrophic lateral sclerosis compared to healthy subjects.


Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
15 01 2021
Historique:
received: 15 06 2020
revised: 08 11 2020
accepted: 25 11 2020
pubmed: 9 12 2020
medline: 15 5 2021
entrez: 8 12 2020
Statut: ppublish

Résumé

Hypermetabolism (HM) in Amyotrophic lateral sclerosis (ALS) is the reflection of a high energy metabolic level, but this alteration seems controversial. The main objective of the study was to confirm the existence of HM during ALS compared to healthy subjects. A cohort of ALS patients was compared to a control group without metabolic disorder. The assessment included anthropometric criteria measurements, body composition by bioelectric impedance analysis and resting energy expenditure (REE) by indirect calorimetry. HM was defined as a variation > +10% between measured and calculated REE. Statistical analysis used Mann-Withney and Chi2 tests. Multivariate analysis included logistic regression. 287 patients and 75 controls were included. The metabolic level was higher in ALS patients (1500 kcal/24 h [1290-1693] vs. 1230 kcal/24 h [1000-1455], p < 0.0001) as well as the REE/fat free mass ratio (33.5 kcal/kg/24 h [30.4-37.8] vs. 28.3 kcal/kg/24 h [26.1-33.6], p < 0.0001). 55.0% of ALS patients had HM vs. 13.3% of controls (p < 0.0001). HM was strongly and positively associated with ALS (OR = 9.50 [4.49-20.10], p < 0.0001). HM in ALS is a reality, which affects more than half of the patients and is associated with ALS. This work confirms a very frequent metabolic deterioration during ALS. The identification of HM can allow a better adaptation of the patients' nutritional intake.

Identifiants

pubmed: 33290920
pii: S0022-510X(20)30593-1
doi: 10.1016/j.jns.2020.117257
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117257

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Philippe Fayemendy (P)

Nutrition Unit, University Hospital of Limoges, Limoges, France; INSERM UMR 1094, Tropical Neuroepidemiology, Limoges, France. Electronic address: philippe.fayemendy@chu-limoges.fr.

Benoit Marin (B)

INSERM UMR 1094, Tropical Neuroepidemiology, Limoges, France; Center for Epidemiology, Biostatistics and Methodology of Research, University Hospital of Limoges, France.

Anaïs Labrunie (A)

Center for Epidemiology, Biostatistics and Methodology of Research, University Hospital of Limoges, France.

Yves Boirie (Y)

University Clermont Auvergne, INRA, UNH, Human Nutrition Unit, CRNH Auvergne, Clermont-Ferrand, France.

Stéphane Walrand (S)

University Clermont Auvergne, INRA, UNH, Human Nutrition Unit, CRNH Auvergne, Clermont-Ferrand, France.

Najate Achamrah (N)

INSERM UMR 1073, Normandie University, Rouen, France.

Moïse Coëffier (M)

INSERM UMR 1073, Normandie University, Rouen, France.

Pierre-Marie Preux (PM)

INSERM UMR 1094, Tropical Neuroepidemiology, Limoges, France; Center for Epidemiology, Biostatistics and Methodology of Research, University Hospital of Limoges, France.

Géraldine Lautrette (G)

ALS center, University Hospital of Limoges, France.

Jean-Claude Desport (JC)

Nutrition Unit, University Hospital of Limoges, Limoges, France; INSERM UMR 1094, Tropical Neuroepidemiology, Limoges, France.

Philippe Couratier (P)

INSERM UMR 1094, Tropical Neuroepidemiology, Limoges, France; ALS center, University Hospital of Limoges, France.

Pierre Jésus (P)

Nutrition Unit, University Hospital of Limoges, Limoges, France; INSERM UMR 1094, Tropical Neuroepidemiology, Limoges, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH